Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes medical devices and services that improve the lives of people living with diabetes.

Stock Performance Snapshot

Hold

Analyst Rating

Analysts suggest holding Tandem Diabetes Care's stock, expecting its value to rise to $20.67.

Above Average

Financial Health

Tandem Diabetes Care is financially healthy with strong revenue and cash flow, supporting its growth.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring TNDM

At-Home Treatment Revolution | FDA Approval Impact

At-Home Treatment Revolution | FDA Approval Impact

The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug signals a major shift in chronic disease management. This creates an investment opportunity in companies that develop advanced drug delivery systems and support at-home patient care.

Published: September 1, 2025

Explore Basket
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

Published: August 19, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Device Adoption Trends

Investors may watch increasing pump and CGM adoption as a demand driver, though uptake can vary by region and payer policies.

⚑

Software Differentiation

Control‑IQ and over‑the‑air updates can extend product value, but software and regulatory issues may affect performance and approvals.

🌍

Market & Reimbursement

Rising diabetes prevalence supports long-term demand; however, reimbursement changes and competition can influence revenue and margins.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

TMO

Thermo Fisher Scientific, Inc.

Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

ISRG

Intuitive Surgical, Inc.

A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties

Frequently asked questions